Business Industry

Key Players |Abbott,Dexcom,F. Hoffmann-La Roche,LifeScan,Medtronic,AgaMatrix,Animas,ARKRAY,Ascensia Diabetes Care,B. Braun Melsungen,BD,Beta Bionics,Bigfoot Biomedical,BIONIME USA,CellNovo,Eli Lilly,iHealth Labs,Insulet,Nemaura Medical,Nipro,Nova Biomedical,Novo Nordisk,Panasonic Healthcare,Prodigy Diabetes Care,Sanofi,Senseonics,Tandem Diabetes Care,Trividia Health,TypeZero Technologies,Valeritas,WellDoc | covered in Diabetes Management Devices market research report 2019

Press Release

Diabetes management devices include insulin delivery systems and blood glucose monitoring devices, which are used to treat diabetes effectively and efficiently with fewer side effects. Diabetes (type 1 and type 2) is a chronic disease condition, which occurs due to glucose impairment. The major factors contributing to the disease include obesity, urbanization, sedentary lifestyle, smoking, an elevated level of cholesterols, and hypertension. Vendors in this market are offering high-end insulin delivery systems (less invasive, sleek, pocket-sized, and portable devices) and continuous glucose monitoring systems, which are highly efficient and have user-friendly features.

Diabetes is a chronic disease and is increasing at a rapid pace across the world. It is that state in the body when the pancreas cannot produce sufficient insulin. Increasing blood sugar level can be a threat and can cause severe damage to the body. The study identifies the rising global burden of diabetes as one of the primary growth factors for diabetes management devices market. Factors responsible for the increase in diabetic population include obesity, smoking, sedentary lifestyle, and growing urbanization. Older people above 65 years are more prone to diabetes. Countries such as China and India have higher diabetic people due to the increase in obesity and urbanization. Owing to the increase in diabetic population across the world, there is an increase in the adoption of diabetes management devices.

Owing to the presence of several large and small players, the diabetes management devices market is highly competitive. To sustain the competition in the diabetes devices market, the vendors are heavily investing in R&D for designing, developing, and manufacturing innovative products. Currently, the emerging markets across the globe provide huge growth opportunities to the vendors in this market space.

The Americas will be the major revenue contributor to the diabetes management devices market throughout the forecast period. Owing to the advancements in technology and the increasing incidence of type 1 and type 2 diabetes, there is an upsurge in the adoption of diabetes management devices in this region.

Global Diabetes Management Devices Market Professional Survey Report 2019 is a professional and in-depth study and available exclusively through Trusted Business Insights. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets in this 111 pages report.

This market report provides in-depth analytics of the Diabetes Management Devices industry including definition, classification, application and industry chain structure. The report focuses on global major leading industry players with information such as company profiles, product picture and specifications, sales, market share, and contact information.

Request for a Sample PDF of Diabetes Management Devices research report

Diabetes Management Devices market report includes an in-depth analysis of the competitive landscape of this business vertical, constituting companies like:

Abbott
Dexcom
F. Hoffmann-La Roche
LifeScan
Medtronic
AgaMatrix
Animas
ARKRAY
Ascensia Diabetes Care
B. Braun Melsungen
BD
Beta Bionics
Bigfoot Biomedical
BIONIME USA
CellNovo
Eli Lilly
iHealth Labs
Insulet
Nemaura Medical
Nipro
Nova Biomedical
Novo Nordisk
Panasonic Healthcare
Prodigy Diabetes Care
Sanofi
Senseonics
Tandem Diabetes Care
Trividia Health
TypeZero Technologies
Valeritas
WellDoc

Products Segmentation, this report displays the production, revenue, price, market share, and growth rate of each type as below:

Blood glucose monitoring device
Insulin delivery systems

By Industrial Application, the market can be split into:

Hospitals
Clinics and laboratories
Others

Market Segment by Regions includes:

  • North America (the USA, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, and Italy)
  • Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
  • South America
  • Middle East and Africa.

Browse contents of Global Diabetes Management Devices Market Professional Survey Report 2019

Contacts

Trusted Business Insights
Jessica Wang
Media & Marketing Executive
[email protected]
US: +1 646 568 9797
UK: +44 330 808 0580